| Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults EJ Anderson, NG Rouphael, AT Widge, LA Jackson, PC Roberts, ... New England Journal of Medicine 383 (25), 2427-2438, 2020 | 1626 | 2020 |
| Durability of responses after SARS-CoV-2 mRNA-1273 vaccination AT Widge, NG Rouphael, LA Jackson, EJ Anderson, PC Roberts, ... New England Journal of Medicine 384 (1), 80-82, 2021 | 822 | 2021 |
| Antibody persistence through 6 months after the second dose of mRNA-1273 vaccine for Covid-19 N Doria-Rose, MS Suthar, M Makowski, S O’Connell, AB McDermott, ... New England Journal of Medicine 384 (23), 2259-2261, 2021 | 699 | 2021 |
| Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants A Pegu, SE O’Connell, SD Schmidt, S O’Dell, CA Talana, L Lai, J Albert, ... Science 373 (6561), 1372-1377, 2021 | 528 | 2021 |
| SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters PJ Halfmann, S Iida, K Iwatsuki-Horimoto, T Maemura, M Kiso, ... Nature 603 (7902), 687-692, 2022 | 512 | 2022 |
| Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells KW Cohen, SL Linderman, Z Moodie, J Czartoski, L Lai, G Mantus, ... Cell Reports Medicine 2 (7), 2021 | 410 | 2021 |
| Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants The New England Journal of Medicine, 2021 | 382 | 2021 |
| Systems vaccinology of the BNT162b2 mRNA vaccine in humans PS Arunachalam, MKD Scott, T Hagan, C Li, Y Feng, F Wimmers, ... Nature 596 (7872), 410-416, 2021 | 375 | 2021 |
| SARS-CoV-2 Omicron variant neutralization after mRNA-1273 booster vaccination R Pajon, NA Doria-Rose, X Shen, SD Schmidt, S O’Dell, C McDanal, ... New England Journal of Medicine 386 (11), 1088-1091, 2022 | 366 | 2022 |
| Adjuvanting a subunit COVID-19 vaccine to induce protective immunity PS Arunachalam, AC Walls, N Golden, C Atyeo, S Fischinger, C Li, P Aye, ... Nature 594 (7862), 253-258, 2021 | 280 | 2021 |
| Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates KS Corbett, MC Nason, B Flach, M Gagne, S O’Connell, TS Johnston, ... Science 373 (6561), eabj0299, 2021 | 253 | 2021 |
| mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron M Gagne, JI Moliva, KE Foulds, SF Andrew, BJ Flynn, AP Werner, ... Cell 185 (9), 1556-1571. e18, 2022 | 216* | 2022 |
| Infection-and vaccine-induced antibody binding and neutralization of the B. 1.351 SARS-CoV-2 variant VV Edara, C Norwood, K Floyd, L Lai, ME Davis-Gardner, WH Hudson, ... Cell host & microbe 29 (4), 516-521. e3, 2021 | 201 | 2021 |
| mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant VV Edara, KE Manning, M Ellis, L Lai, KM Moore, SL Foster, K Floyd, ... Cell Reports Medicine 3 (2), 2022 | 200 | 2022 |
| Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation NK Hurlburt, E Seydoux, YH Wan, VV Edara, AB Stuart, J Feng, ... Nature communications 11 (1), 5413, 2020 | 187 | 2020 |
| Neutralizing antibodies against SARS-CoV-2 variants after infection and vaccination VV Edara, WH Hudson, X Xie, R Ahmed, MS Suthar Jama 325 (18), 1896-1898, 2021 | 150 | 2021 |
| Defining the risk of SARS-CoV-2 variants on immune protection MM DeGrace, E Ghedin, MB Frieman, F Krammer, A Grifoni, A Alisoltani, ... Nature 605 (7911), 640-652, 2022 | 137 | 2022 |
| Activated human astrocyte-derived extracellular vesicles modulate neuronal uptake, differentiation and firing Y You, K Borgmann, VV Edara, S Stacy, A Ghorpade, T Ikezu Journal of extracellular vesicles 9 (1), 1706801, 2020 | 137 | 2020 |
| The SARS-CoV-2 B. 1.1. 529 Omicron virus causes attenuated infection and disease in mice and hamsters M Diamond, P Halfmann, T Maemura, K Iwatsuki-Horimoto, S Iida, M Kiso, ... Research square, 2021 | 115 | 2021 |
| Development of a rapid focus reduction neutralization test assay for measuring SARS‐CoV‐2 neutralizing antibodies A Vanderheiden, VV Edara, K Floyd, RC Kauffman, G Mantus, ... Current protocols in immunology 131 (1), e116, 2020 | 112 | 2020 |
